Siga Technologies (NASDAQ:SIGA – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.09) earnings per share for the quarter, Zacks reports. The firm had revenue of $2.62 million for the quarter. Siga Technologies had a return on equity of 40.52% and a net margin of 45.73%.
Siga Technologies Stock Down 19.3%
Shares of NASDAQ:SIGA traded down $1.58 during trading on Friday, hitting $6.60. 582,008 shares of the company were exchanged, compared to its average volume of 466,021. Siga Technologies has a 1-year low of $4.95 and a 1-year high of $9.62. The company has a market capitalization of $472.24 million, a P/E ratio of 5.84 and a beta of 0.93. The business’s 50 day moving average is $8.59 and its 200-day moving average is $7.38.
Hedge Funds Weigh In On Siga Technologies
A number of institutional investors and hedge funds have recently bought and sold shares of the company. BNP Paribas Financial Markets raised its position in Siga Technologies by 34.1% in the second quarter. BNP Paribas Financial Markets now owns 4,661 shares of the company’s stock valued at $30,000 after purchasing an additional 1,184 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Siga Technologies by 116.6% in the second quarter. Tower Research Capital LLC TRC now owns 6,817 shares of the company’s stock valued at $44,000 after buying an additional 3,669 shares during the period. Russell Investments Group Ltd. raised its holdings in Siga Technologies by 57.6% in the 2nd quarter. Russell Investments Group Ltd. now owns 15,637 shares of the company’s stock valued at $102,000 after buying an additional 5,712 shares during the last quarter. Strs Ohio bought a new position in Siga Technologies in the 1st quarter valued at approximately $165,000. Finally, Oxford Asset Management LLP acquired a new stake in Siga Technologies during the 2nd quarter worth approximately $177,000. Institutional investors and hedge funds own 55.40% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Research Report on SIGA
Siga Technologies Company Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Featured Stories
- Five stocks we like better than Siga Technologies
- How is Compound Interest Calculated?
- Amgen Stock: New All-Time Highs Ahead After Earnings Beat
- How to Invest in Small Cap StocksÂ
- Netflix Stock Split Explained: What It Means for Investors
- Want to Profit on the Downtrend? Downtrends, Explained.
- SoundHound Beat Earnings & Dropped—Here’s What Wall Street Missed
Receive News & Ratings for Siga Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siga Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
